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and well perfused. Graft function began to deteriorate, with
worsening infiltrates on chest radiography and increasing
mechanical ventilatory requirements with peak inspiratory
pressures as high as 53 cm H2O. An open lung biopsy per-
formed 2 weeks after initial transplantation revealed acute cel-
lular rejection, active bronchiolitis obliterans, and severe alve-
olar damage. She was treated with pulsed steroids and relisted
for heart-lung transplantation. In response to progressive graft
dysfunction, the immunosuppression therapy was augmented
with antithymocyte globulin. During an episode of severe
hypoxemia with an inability to ventilate, bronchoscopy
revealed a contained tracheal disruption with pulsatile granu-
lation tissue. Thick secretions and thrombus were removed
with improved ventilation. Review of the chest radiographs
revealed a paratracheal lucency suggestive of anastomotic dis-
ruption. A recurrent episode of hypoxemia with difficult ven-
tilation occurred, and repeat bronchoscopy revealed complete
disruption of the trachea with a large pulsatile mass posterior-
ly, which virtually occluded the airway. She was then taken to
the operating room for further exploration.
The exploratory operation was done through a median ster-
notomy with the aid of cardiopulmonary bypass. A large
mediastinal hematoma was evacuated, and complete dehis-
cence of the tracheal anastomosis, with separation of nearly 3
cm between the ends of the proximal native and distal donor
trachea, was found. The distal trachea was destroyed at the
level of the bifurcation, with very little cartilage remaining at
the carina. The proximal trachea was mobilized extensively to
the neck, with care taken to preserve the lateral blood supply.
It was not possible to mobilize the distal tracheal because of
the inflammatory reaction and scarring. Even with flexion of
the neck, it was not possible to approximate the ends of the
trachea. Therefore, direct tracheal reconstruction was aban-
doned, and a 22-mm aortic homograft was used as an interpo-
sition graft to bridge the gap between the 2 ends of the tra-
chea. The homograft-tracheal anastomoses were performed
with continuous Prolene sutures. The airways were evacuated
of a large amount of blood, and ventilation was reinitiated. An
airtight anastomosis was ensured, and the lungs were ventilat-
ed adequately. She continued to require very high inflating
pressures caused by the graft dysfunction and had superior
vena cava syndrome caused by a mediastinal clot in conjunc-
tion with the high ventilatory pressure.
Three days after placement of the aortic homograft, a suit-
able heart-lung graft became available, and she underwent
repeat transplantation with tracheal reconstruction. Inspection
of the aortic homograft revealed the anastomosis to be intact,
without air leak, and with mild discoloration from mediastinal
Airway complications after heart-lung transplantation
include poor tracheal healing, mucosal slough, stricture,
partial disruption, and complete dehiscence of the anasto-
mosis.1-3 Complete dehiscence or disruption of the tracheal
anastomosis is a rare but often lethal complication.2 We
describe the treatment of a patient with acute graft failure
and complete tracheal anastomotic disruption after heart-
lung transplantation.
Clinical summary. A 38-year-old woman had pulmonary
hypertension after a ventricular septal defect closure at 5 years
of age. She was hospitalized for 3 months before transplanta-
tion with severe right-sided heart failure with ascites,
hepatomegaly, weight loss, and marked muscle wasting,
despite therapy with epoprostenol (Flotan) and inotropic med-
ications. Orthotopic heart-lung transplantation was performed
with a graft ischemic time of 305 minutes. The donor trachea
was divided 2 rings above the carina, and the recipient’s tra-
chea was divided at the level of the carina. An end-to-end tra-
cheal anastomosis was performed with a continuous Prolene
suture (Ethicon, Inc, Somerville, NJ) for the membranous por-
tion and interrupted Prolene sutures for the anterior cartilagi-
nous portion. The donor-recipient size match was excellent,
and no air leak was noted intraoperatively. Tissue was tacked
around the tracheal suture line to separate the anastomosis
from the aorta.
Postoperatively, she was maintained on triple immunosup-
pression therapy consisting of intravenous cyclosporine
(Sandimmune; INN: ciclosporin), azathioprine, and steroids;
once she was able to tolerate enteral medications,
cyclosporine was changed to tacrolimus. She was extubated
on postoperative day 4 but required reintubation within 30
hours because of muscle weakness and an inability to
phonate, cough, and mobilize respiratory secretions. She was
examined with a flexible bronchoscope the next day, revealing
an intact, widely patent tracheal anastomosis. There was min-
imal mucosal necrosis of the membranous portion of the
donor trachea. The remainder of the mucosa appeared viable
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clot. A bronchoscopic examination performed 5 days after
retransplantation revealed a well-perfused distal donor tra-
chea and minimal inflammation. The anastomosis was intact
and widely patent, with a very small amount of mucosal
sloughing posteriorly on the membranous trachea. The sec-
ond heart-lung transplant was complicated by hyperammone-
mia with resultant encephalopathy and electrolyte abnormal-
ities. This was managed successfully with a combination of
sodium benzoate and phenylacetate and arginine hydrochlo-
ride, as well as continuous intracranial pressure monitoring
and venovenous hemodialysis, as has been previously
described.4 Because of the inability to clear secretions and
documented vocal cord paresis, a tracheostomy was per-
formed. She was discharged from the hospital approximately
2 months after the second transplant operation after extensive
physical, respiratory, and occupational rehabilitation. The tra-
chea has since been decannulated. At last follow-up and cor-
respondence (1 year after transplantation), she has good graft
function, has normal exercise tolerance, and is able to inde-
pendently perform activities of daily living. There are no neu-
rologic sequelae of her hyperammonemic coma.
Discussion. Healing of the tracheal anastomosis after
heart-lung transplantation is dependent on adequate blood
supply to the donor trachea. The normal tracheal blood sup-
ply is disrupted during harvest of the heart-lung block.
After transplantation, blood supply to the donor trachea
derives from collateral vessels to the transplanted organ,
including coronary-bronchial vessels. A variety of factors
may jeopardize this tenuous blood supply, including excess
length of the donor trachea and hemodynamic instability. In
addition, graft dysfunction with poor lung compliance
necessitating the use of high mean airway pressures may
impair mucosal perfusion and contribute to poor healing of
the tracheal anastomosis. Many operative techniques have
been designed to protect the anastomosis. These include
omentopexy to neovascularize the bronchial anastomoses
and a pericardial flap-plasty or a pericardial fat pad, both of
which are used as a protective wrap.2,3 Additionally, revas-
cularization with an internal thoracic artery–bronchial
artery graft has been described.5
Complications, such as partial disruption and anastomotic
strictures, can often be managed conservatively, whereas
complete tracheal disruption is a catastrophic event present-
ing with airway obstruction, massive air leaks, or develop-
ment of aorta-tracheal fistulas with exsanguination.
Restoration of airway continuity is the goal of therapy. An
end-to-end repair is usually not possible because of necrosis
of a significant portion of the donor trachea; this may also
preclude mediastinal tracheostomy. The results of prosthetic
replacement of the trachea with glass, metal, or silicone rub-
ber have been poor. Placement of tracheal homograft is an
option, but availability is limited.
Our patient had been relisted for transplantation because of
graft dysfunction, and thus a temporary means to restore air-
way continuity was needed to bridge to retransplantation. An
aortic homograft was placed as an interposition graft to
restore airway continuity. The patient underwent successful
repeat heart-lung transplant 3 days later.
Aortic homografts are widely available in a variety of sizes.
Insertion as an interposition graft in this case was technically
straightforward. The homograft tissue is not rigid, and thus
continued positive pressure ventilation is necessary. Although
the homograft cannot serve as a permanent tracheal replace-
ment, use of an aortic homograft to restore airway continuity
is an option for interim management of airway disruption
after heart-lung transplantation.
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